Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Pappa · SciRah

Researcher profile · Semantic Scholar

V. Pappa

Share profile

V. Pappa — researcher profile on SciRah

h-index: 24
Works: 168
Citations: 2,027

Most-cited papers

SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors
E. Terpos, D. Stellas, M. Rosati, T. Sergentanis +13 more
2021European journal of internal medicine63 citations Open access
Semantic Scholar
PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy
T. Vassilakopoulos, G. Pangalis, Sofia Chatziioannou, S. Papageorgiou +34 more
2016Leukemia48 citations
Semantic Scholar
Anti–SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study
E. Terpos, M. Politou, T. Sergentanis, A. Mentis +29 more
2020Microorganisms41 citations Open access
Semantic Scholar
Prognostic indicators for mycosis fungoides in a Greek population
V. Nikolaou, E. Papadavid, A. Patsatsi, M. Siakantaris +7 more
2017British Journal of Dermatology38 citations
Semantic Scholar
Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas
M. Dimou, S. Papageorgiou, N. Stavroyianni, E. Katodritou +31 more
2021Hematological Oncology34 citations
Semantic Scholar
ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristics
Katerina Kakosaiou, F. Panitsas, A. Daraki, M. Pagoni +9 more
2018Leukemia and Lymphoma29 citations
Semantic Scholar
The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients
A. Koumarianou, Marianna Christodoulou, P. Patapis, I. Papadopoulos +10 more
2014Experimental Hematology & Oncology29 citations Open access
Semantic Scholar
KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia.
P. Adamopoulos, C. Kontos, S. Papageorgiou, V. Pappa +1 more
2015Clinical Biochemistry26 citations
Semantic Scholar
Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications
S. Papageorgiou, T. Thomopoulos, Ioannis Katagas, A. Bouchla +1 more
2021Therapeutic Advances in Hematology25 citations Open access
Semantic Scholar
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.
T. Vassilakopoulos, M. Michail, S. Papageorgiou, G. Kourti +49 more
2021The Oncologist24 citations Open access
Semantic Scholar
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies
T. Vassilakopoulos, S. Papageorgiou, M. Angelopoulou, S. Chatziioannou +46 more
2021Annals of Hematology22 citations
Semantic Scholar
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival
E. Katodritou, M. Kyrtsonis, S. Delimpasi, D. Kyriakou +24 more
2018Annals of Hematology19 citations Open access
Semantic Scholar
The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine
P. Miltiades, E. Lamprianidou, T. Vassilakopoulos, S. Papageorgiou +14 more
2015Clinical Cancer Research17 citations
Semantic Scholar
Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute Leukemia
P. Tsirigotis, K. Gkirkas, V. Kitsiou, S. Chondropoulos +8 more
2021Cancers15 citations Open access
Semantic Scholar
Splenic irradiation as palliative treatment for symptomatic splenomegaly due to secondary myelofibrosis: a multi-institutional experience.
K. Pistevou-Gombaki, A. Zygogianni, I. Kantzou, G. Kyrgias +11 more
2015Journal of B.U.ON. : official journal of the Balkan Union of Oncology15 citations
Semantic Scholar
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
J. Kiladjian, F. Marín, H. Al-Ali, A. Álvarez-Larrán +37 more
2024Annals of Hematology14 citations Open access
Semantic Scholar
Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine
M. Tsirogianni, E. Grigoriou, Violetta Kapsimalli, Kleopatra Dagla +10 more
2019Leukemia and Lymphoma14 citations
Semantic Scholar
mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients
C. Kontos, P. Adamopoulos, S. Papageorgiou, V. Pappa +1 more
2016Clinical Chemistry and Laboratory Medicine14 citations
Semantic Scholar
Chronic myelomonocytic leukemia treated with 5-azacytidine – results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system
P. Diamantopoulos, I. Kotsianidis, A. Symeonidis, V. Pappa +17 more
2018Leukemia and Lymphoma13 citations
Semantic Scholar
Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes
Panagiotis T. Diamantopoulos, Konstantinos Zervakis, Panagiotis Zervakis, Maria Sofotasiou +12 more
2017Blood Cancer Journal13 citations Open access
Semantic Scholar
DNA Damage Response/Repair in Cancer Stem Cells — Potential vs. Controversies
M. Louka, E. Boutou, Vasiliki Bakou, V. Pappa +4 more
201511 citations Open access
Semantic Scholar
Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3- T cells represents a potential antitumor mechanism of azacitidine.
E. Lamprianidou, C. Kordella, A. Kazachenka, E. Zoulia +16 more
2021Blood Advances10 citations Open access
Semantic Scholar
The prognostic value of monosomal karyotype (MK) in higher‐risk patients with myelodysplastic syndromes treated with 5‐Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group
S. Papageorgiou, Diamantina Vasilatou, C. Kontos, I. Kotsianidis +14 more
2018American journal of hematology/oncology10 citations Open access
Semantic Scholar
Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison
S. Papiris, P. Tsirigotis, C. Kannengiesser, L. Kolilekas +12 more
2019Respiratory Research9 citations Open access
Semantic Scholar
Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome
P. Diamantopoulos, Emmanouil Charakopoulos, A. Symeonidis, I. Kotsianidis +19 more
2022Scientific Reports8 citations Open access
Semantic Scholar
Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome
P. Diamantopoulos, Christina-Nefeli Kontandreopoulou, A. Symeonidis, I. Kotsianidis +14 more
2019Annals of Hematology8 citations
Semantic Scholar
Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis
P. Tsirigotis, T. Vassilakopoulos, I. Batsis, Z. Bousiou +26 more
2018Hematological Oncology8 citations
Semantic Scholar
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma
S. Karakatsanis, M. Bouzani, A. Symeonidis, M. Angelopoulou +49 more
2022In Vivo7 citations Open access
Semantic Scholar
Primary non-Hodgkin lymphoma of the extra-hepatic bile duct: A case report
N. Pararas, P. Foukas, Andreas Pikoulis, G. Bagias +4 more
2022Molecular and clinical oncology7 citations Open access
Semantic Scholar
Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries
K. Liapis, V. Papadopoulos, C. Pontikoglou, G. Vrachiolias +28 more
2023Leukemia6 citations
Semantic Scholar
PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?
T. Vassilakopoulos, A. Piperidou, Z. Mellios, Evgenia Verigou +43 more
2023HemaSphere6 citations Open access
Semantic Scholar
Endothelial glycocalyx integrity in oncological patients.
K. Keramida, J. Thymis, M. Anastasiou, K. Katogiannis +9 more
2022International Journal of Cardiology6 citations Open access
Semantic Scholar
Allogeneic Stem Cell Transplantation with a Novel Reduced Intensity Conditioning Regimen for the Treatment of Patients with Primary Cutaneous T-cell Lymphomas
M. Stamouli, K. Gkirkas, A. Karagiannidi, T. Iliakis +6 more
2021Clinical Hematology International6 citations Open access
Semantic Scholar
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS)
A. Symeonidis, P. Diamantopoulos, A. Galanopoulos, A. Kourakli +34 more
2025Cancers5 citations Open access
Semantic Scholar
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients with Myelodysplastic Syndromes/Neoplasms (MDS): An Analysis from the International Consortium for MDS (icMDS) Validate Database
Benjamin Rolles, J. Bewersdorf, Tariq Kewan, O. Bláha +54 more
2024Blood5 citations
Semantic Scholar
Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS)
I. Kotsianidis, S. Papageorgiou, V. Pappa, A. Galanopoulos +9 more
2019Mediterranean Journal of Hematology and Infectious Diseases5 citations Open access
Semantic Scholar
Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection
P. Diamantopoulos, Christina-Nefeli Kontandreopoulou, C. Stafylidis, D. Vlachopoulou +9 more
2022Annals of Hematology4 citations Open access
Semantic Scholar
Myelodysplastic Syndromes (MDS) Presenting with Isolated Thrombocytopenia: Characteristics, Outcomes, and Clinical Presentation Differences from Immune Thrombocytopenic Purpura (ITP)
K. Liapis, V. Papadopoulos, G. Vrachiolias, E. Stavroulaki +28 more
2021Blood4 citations Open access
Semantic Scholar
Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study
K. Liapis, Georgios Vrachiolias, V. Papadopoulos, A. Kourakli +16 more
2020eJHaem4 citations Open access
Semantic Scholar
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax—an analysis from the International Consortium for MDS (icMDS) VALIDATE database
J. Bewersdorf, Tariq Kewan, L. Lanino, Wei Wei +55 more
2026Blood Cancer Journal3 citations Open access
Semantic Scholar
Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real‐world data from a multicentre study
V. Nikolaou, E. Panou, Antonios Tsimpidakis, Ioannis-Alexios Koumprentziotis +18 more
2024Journal of the European Academy of Dermatology and Venereology3 citations Open access
Semantic Scholar
Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes
K. Liapis, V. Papadopoulos, G. Vrachiolias, A. Galanopoulos +24 more
2021Blood Cancer Journal3 citations Open access
Semantic Scholar
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher‐risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes
V. Papadopoulos, P. Diamantopoulos, S. Papageorgiou, M. Papoutselis +18 more
2020Hematological Oncology3 citations
Semantic Scholar
Ropeginterferon alfa-2b in essential thrombocythemia of all risk levels ineligible for standard cytoreduction: 12-month primary endpoint analysis from the ROP-ET phase 3 study
J. Kiladjian, H. Al-Ali, Jiří Mayer, C. Tomuleasa +29 more
2025Blood2 citations
Semantic Scholar
Micrornas Analysis in Patients with Myelodysplastic Syndrome. Possible Implications in Risk Stratification
Christina-Nefeli Kontandreopoulou, S. Syriopoulou, P. Diamantopoulos, Nefeli Giannakopoulou +12 more
2022Blood2 citations Open access
Semantic Scholar
Rapid Reduction of Anti-Sars-Cov-2 Antibodies in Convalescent Plasma Donors; Results of a Phase 2 Clinical Study
E. Terpos, M. Politou, T. Sergentanis, A. Mentis +22 more
2020Blood2 citations Open access
Semantic Scholar
THE tRNA‐DERIVED RNA FRAGMENTS (tRFs) BEARING THE GLYCINE ANTICODONS GCC AND CCC AS EMERGING MOLECULAR BIOMARKERS OF UNFAVORABLE PROGNOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA
S. Papageorgiou, Katerina Katsaraki, Paraskevi Karousi, Panagiotis Tsiakanikas +3 more
2019Hematological Oncology2 citations
Semantic Scholar
Efficacy and safety of Brentuximab Vedotin in advanced cutaneous T‐Cell lymphomas patients
E. Papadavid, E. Kapniari, L. Marinos, Vasiliki Nikolaou +5 more
2019Journal of the European Academy of Dermatology and Venereology2 citations
Semantic Scholar
Outcomes of patients (pts) with higher-risk myelodysplastic syndromes (HR-MDS) treated with hypomethylating agents (HMA) + venetoclax (VEN) – a large analysis from the international consortium for MDS (icMDS) validate database
J. Bewersdorf, Tariq Kewan, L. Lanino, Wei Wei +53 more
2025Blood1 citations
Semantic Scholar
The Prognostic Significance of Serum β2- Microglobulin Levels (sβ2m) in Diffuse Large B-Cell Lymphoma (DLBCL)
M. Arapaki, E. Verrou, S. Papageorgiou, A. Anastasopoulou +19 more
2024Blood1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Papageorgiou×26
Invite
S. Papageorgiou — researcher profile on SciRah
T. Vassilakopoulos×18
Invite
T. Vassilakopoulos — researcher profile on SciRah
P. Panayiotidis×18
Invite
P. Panayiotidis — researcher profile on SciRah
E. Hatzimichael×17
Invite
E. Hatzimichael — researcher profile on SciRah

×15

Invite

I. Kotsianidis — researcher profile on SciRah

A. Galanopoulos×15

Invite

A. Galanopoulos — researcher profile on SciRah

Invite

N. Viniou — researcher profile on SciRah

A. Symeonidis×14

Invite

A. Symeonidis — researcher profile on SciRah

P. Diamantopoulos×12

Invite

P. Diamantopoulos — researcher profile on SciRah

Invite

M. Dimou — researcher profile on SciRah

H. Papadaki×10

Invite

H. Papadaki — researcher profile on SciRah

A. Kourakli×10

Invite

A. Kourakli — researcher profile on SciRah